glaucoma

Scientific Reports, Published online: 11 June 2026; doi:10.1038/s41598-026-57462-w Corvis ST parameters in primary open angle and angle closure glaucoma after propensity score matching

IntroductionTo evaluate the efficacy of a novel eye drop formulation containing hyaluronic acid (0.2%) and butyroyl-glutathione (GSHC4, 0.4%) in glaucoma-associated ocular surface disease (G-OSD), and to explore putative mechanisms of action through in vitro assays of corneal epithelial wound healing and cytokine modulation under basal, inflammatory, and oxidative stress conditions.MethodsIn this…

Developing therapies for common vision disorders such as glaucoma is complex – compounds must first cross into the brain before protecting neurons, all without wreaking havoc themselves. In research published in IBRO journal Neuroscience, a peptide tested in mice appears to do all these things, highlighting its potential as a treatment for glaucoma and other […] The post Peptide holds promise as …